Copyright Reports & Markets. All rights reserved.

Global Controlled Substances Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Controlled Substances Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Opioids
      • 1.4.3 Stimulants
      • 1.4.4 Depressants
      • 1.4.5 Marijuana
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Controlled Substances Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Controlled Substances Market Size
    • 2.2 Controlled Substances Growth Trends by Regions
      • 2.2.1 Controlled Substances Market Size by Regions (2014-2025)
      • 2.2.2 Controlled Substances Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Controlled Substances Market Size by Manufacturers
      • 3.1.1 Global Controlled Substances Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Controlled Substances Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Controlled Substances Market Concentration Ratio (CR5 and HHI)
    • 3.2 Controlled Substances Key Players Head office and Area Served
    • 3.3 Key Players Controlled Substances Product/Solution/Service
    • 3.4 Date of Enter into Controlled Substances Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Controlled Substances Market Size by Type (2014-2019)
    • 4.2 Global Controlled Substances Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Controlled Substances Market Size (2014-2019)
    • 5.2 Controlled Substances Key Players in United States
    • 5.3 United States Controlled Substances Market Size by Type
    • 5.4 United States Controlled Substances Market Size by Application

    6 Europe

    • 6.1 Europe Controlled Substances Market Size (2014-2019)
    • 6.2 Controlled Substances Key Players in Europe
    • 6.3 Europe Controlled Substances Market Size by Type
    • 6.4 Europe Controlled Substances Market Size by Application

    7 China

    • 7.1 China Controlled Substances Market Size (2014-2019)
    • 7.2 Controlled Substances Key Players in China
    • 7.3 China Controlled Substances Market Size by Type
    • 7.4 China Controlled Substances Market Size by Application

    8 Japan

    • 8.1 Japan Controlled Substances Market Size (2014-2019)
    • 8.2 Controlled Substances Key Players in Japan
    • 8.3 Japan Controlled Substances Market Size by Type
    • 8.4 Japan Controlled Substances Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Controlled Substances Market Size (2014-2019)
    • 9.2 Controlled Substances Key Players in Southeast Asia
    • 9.3 Southeast Asia Controlled Substances Market Size by Type
    • 9.4 Southeast Asia Controlled Substances Market Size by Application

    10 India

    • 10.1 India Controlled Substances Market Size (2014-2019)
    • 10.2 Controlled Substances Key Players in India
    • 10.3 India Controlled Substances Market Size by Type
    • 10.4 India Controlled Substances Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Controlled Substances Market Size (2014-2019)
    • 11.2 Controlled Substances Key Players in Central & South America
    • 11.3 Central & South America Controlled Substances Market Size by Type
    • 11.4 Central & South America Controlled Substances Market Size by Application

    12 International Players Profiles

    • 12.1 Johnson & Johnson
      • 12.1.1 Johnson & Johnson Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Controlled Substances Introduction
      • 12.1.4 Johnson & Johnson Revenue in Controlled Substances Business (2014-2019)
      • 12.1.5 Johnson & Johnson Recent Development
    • 12.2 Pfizer
      • 12.2.1 Pfizer Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Controlled Substances Introduction
      • 12.2.4 Pfizer Revenue in Controlled Substances Business (2014-2019)
      • 12.2.5 Pfizer Recent Development
    • 12.3 Siegfried AG
      • 12.3.1 Siegfried AG Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Controlled Substances Introduction
      • 12.3.4 Siegfried AG Revenue in Controlled Substances Business (2014-2019)
      • 12.3.5 Siegfried AG Recent Development
    • 12.4 GlaxoSmithKline
      • 12.4.1 GlaxoSmithKline Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Controlled Substances Introduction
      • 12.4.4 GlaxoSmithKline Revenue in Controlled Substances Business (2014-2019)
      • 12.4.5 GlaxoSmithKline Recent Development
    • 12.5 Teva Pharmaceuticals
      • 12.5.1 Teva Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Controlled Substances Introduction
      • 12.5.4 Teva Pharmaceuticals Revenue in Controlled Substances Business (2014-2019)
      • 12.5.5 Teva Pharmaceuticals Recent Development
    • 12.6 Mylan
      • 12.6.1 Mylan Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Controlled Substances Introduction
      • 12.6.4 Mylan Revenue in Controlled Substances Business (2014-2019)
      • 12.6.5 Mylan Recent Development
    • 12.7 Takeda Pharmaceutical
      • 12.7.1 Takeda Pharmaceutical Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Controlled Substances Introduction
      • 12.7.4 Takeda Pharmaceutical Revenue in Controlled Substances Business (2014-2019)
      • 12.7.5 Takeda Pharmaceutical Recent Development
    • 12.8 Sun Pharmaceutical
      • 12.8.1 Sun Pharmaceutical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Controlled Substances Introduction
      • 12.8.4 Sun Pharmaceutical Revenue in Controlled Substances Business (2014-2019)
      • 12.8.5 Sun Pharmaceutical Recent Development
    • 12.9 Daiichi Sankyo
      • 12.9.1 Daiichi Sankyo Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Controlled Substances Introduction
      • 12.9.4 Daiichi Sankyo Revenue in Controlled Substances Business (2014-2019)
      • 12.9.5 Daiichi Sankyo Recent Development
    • 12.10 Akorn Inc
      • 12.10.1 Akorn Inc Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Controlled Substances Introduction
      • 12.10.4 Akorn Inc Revenue in Controlled Substances Business (2014-2019)
      • 12.10.5 Akorn Inc Recent Development
    • 12.11 Tilray
    • 12.12 Medical Marijuana, Inc
    • 12.13 Consort Medical
    • 12.14 Purdue Pharma

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      North America has traditionally been the most lucrative market for controlled substances, with sales estimated to record a Y-o-Y of 5.0% in 2019 over 2018. This can be attributes in part to legalization of various forms of marijuana in the US, along with the recent approval of recreational marijuana sales in Canada.
      In 2018, the global Controlled Substances market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Controlled Substances status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Controlled Substances development in United States, Europe and China.

      The key players covered in this study
      Johnson & Johnson
      Pfizer
      Siegfried AG
      GlaxoSmithKline
      Teva Pharmaceuticals
      Mylan
      Takeda Pharmaceutical
      Sun Pharmaceutical
      Daiichi Sankyo
      Akorn Inc
      Tilray
      Medical Marijuana, Inc
      Consort Medical
      Purdue Pharma

      Market segment by Type, the product can be split into
      Opioids
      Stimulants
      Depressants
      Marijuana
      Others

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Controlled Substances status, future forecast, growth opportunity, key market and key players.
      To present the Controlled Substances development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Controlled Substances are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now